{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:51:32Z","timestamp":1776498692732,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ygyno.2014.03.563","type":"journal-article","created":{"date-parts":[[2014,3,25]],"date-time":"2014-03-25T01:16:43Z","timestamp":1395710203000},"page":"473-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma"],"prefix":"10.1016","volume":"133","author":[{"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd B.","family":"Sheridan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley D.","family":"Studeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight D.","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil B.","family":"Rosenshein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2014.03.563_bb0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.ygyno.2014.03.563_bb0010","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543784.2010.515585","article-title":"Overcoming platinum resistance in ovarian carcinoma","volume":"19","author":"Matsuo","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"issue":"9","key":"10.1016\/j.ygyno.2014.03.563_bb0015","first-page":"723","article-title":"Recurrent ovarian cancer","volume":"3","author":"Tummala","year":"2005","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/cam4.31","article-title":"Significance of lymphovascular space invasion in epithelial ovarian cancer","volume":"1","author":"Matsuo","year":"2012","journal-title":"Cancer Med"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0025","doi-asserted-by":"crossref","DOI":"10.1097\/AOG.0000000000000240","article-title":"Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer","author":"Matsuo","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.03.563_bb0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1385\/ENDO:26:3:297","article-title":"Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation","volume":"26","author":"Prior","year":"2005","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ygyno.2012.10.013","article-title":"Quantification of ER\/PR expression in ovarian low-grade serous carcinoma","volume":"128","author":"Escobar","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2014.03.563_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1470-2045(13)70253-5","article-title":"Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study","volume":"14","author":"Sieh","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.03.563_bb0045","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0029-7844(97)00118-X","article-title":"Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case\u2013control study","volume":"89","author":"Hempling","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ygyno.2014.03.563_bb0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00001622-200109000-00012","article-title":"Hormone replacement therapy and cancer risk","volume":"13","author":"Mahavni","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0055","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/oxfordjournals.aje.a117518","article-title":"Estrogen replacement therapy and fatal ovarian cancer","volume":"141","author":"Rodriguez","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.ygyno.2014.03.563_bb0060","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.steroids.2013.01.008","article-title":"New insights on the role of hormonal therapy in ovarian cancer","volume":"78","author":"Simpkins","year":"2013","journal-title":"Steroids"},{"issue":"9574","key":"10.1016\/j.ygyno.2014.03.563_bb0065","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","article-title":"Ovarian cancer and hormone replacement therapy in the Million Women Study","volume":"369","author":"Beral","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0070","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/gyno.1996.0315","article-title":"Estrogen replacement therapy and risk of epithelial ovarian cancer","volume":"63","author":"Risch","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.ygyno.2014.03.563_bb0075","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1158\/1078-0432.CCR-08-2525","article-title":"Estrous cycle modulates ovarian carcinoma growth","volume":"15","author":"Armaiz-Pena","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1210\/endo.133.2.8344219","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth","volume":"133","author":"Cullinan-Bove","year":"1993","journal-title":"Endocrinology"},{"issue":"Suppl. 5","key":"10.1016\/j.ygyno.2014.03.563_bb0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1289\/ehp.00108s5785","article-title":"Regulation of vascular endothelial growth factor expression by estrogens and progestins","volume":"108","author":"Hyder","year":"2000","journal-title":"Environ Health Perspect"},{"issue":"12","key":"10.1016\/j.ygyno.2014.03.563_bb0090","first-page":"3183","article-title":"Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor","volume":"60","author":"Hyder","year":"2000","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.ygyno.2014.03.563_bb0095","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/ijc.24654","article-title":"Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer","volume":"125","author":"Matsuo","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/COC.0b013e3181ec5f4b","article-title":"Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"34","author":"Matsuo","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-2407-7-56","article-title":"Estrogen receptor alpha (ER alpha) mRNA copy numbers in immunohistochemically ER alpha-positive-, and negative breast cancer tissues","volume":"7","author":"Poola","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jtcvs.2006.10.019","article-title":"Chemotherapy resistance and oncogene expression in non-small cell lung cancer","volume":"133","author":"d'Amato","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.ygyno.2014.03.563_bb0115","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.ygyno.2014.03.563_bb0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ygyno.2011.09.017","article-title":"Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer","volume":"124","author":"Guntupalli","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ygyno.2005.12.027","article-title":"Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva","volume":"102","author":"Raspagliesi","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2014.03.563_bb0130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/gyno.1998.4943","article-title":"Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix","volume":"68","author":"Roman","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"26","key":"10.1016\/j.ygyno.2014.03.563_bb0135","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ygyno.2014.03.563_bb0140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1517\/14712598.2012.745508","article-title":"Contemporary use of bevacizumab in ovarian cancer","volume":"13","author":"Miyake","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ygyno.2014.03.563_bb0145","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"issue":"2 Pt 2","key":"10.1016\/j.ygyno.2014.03.563_bb0150","doi-asserted-by":"crossref","first-page":"865s","DOI":"10.1158\/1078-0432.865s.11.2","article-title":"Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer","volume":"11","author":"Osborne","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.ygyno.2014.03.563_bb0155","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1158\/1078-0432.CCR-12-0662","article-title":"The PI3K\/AKT\/mTOR pathway as a therapeutic target in endometrial cancer","volume":"18","author":"Slomovitz","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814008051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825814008051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T09:23:15Z","timestamp":1689067395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825814008051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0090825814008051"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.03.563","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2014.03.563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}